Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia, Kidney Disease, Chronic”

Showing 20 of 0 results

Not applicableStudy completedNCT01356589
What this trial is testing

MIRCERA for the Intrapetient Variability of Hemoglobin Levels in Patients With Chronic Renal Anemia (RIVAL)

Who this might be right for
Anemia
Hoffmann-La Roche 1,288
Testing effectiveness (Phase 2)Study completedNCT01975818
What this trial is testing

Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934

Who this might be right for
AnemiaRenal Insufficiency, Chronic
Bayer 201
Very early researchEnded earlyNCT02228655
What this trial is testing

An Exploratory Study to Evaluate FMX-8 to Treat Anemia in CKD

Who this might be right for
Anemia in Chronic Kidney Disease
FerruMax Pharmaceuticals, Inc. 2
Testing effectiveness (Phase 2)Study completedNCT02079896
What this trial is testing

Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients

Who this might be right for
AnemiaEnd Stage Renal Disease
TME Pharma AG 33
Large-scale testing (Phase 3)Study completedNCT02052310
What this trial is testing

Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants

Who this might be right for
Anemia in Incident Dialysis Patients
Kyntra Bio 1,043
Large-scale testing (Phase 3)Study completedNCT02988973
What this trial is testing

Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia

Who this might be right for
Chronic Kidney Disease
Astellas Pharma Inc 334
Not applicableStudy completedNCT02042833
What this trial is testing

An Observational Study of Patients' Perception of Treatment With Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease Not on Dialysis (PERCEPOLIS)

Who this might be right for
Anemia
Hoffmann-La Roche 815
Large-scale testing (Phase 3)Study completedNCT00124098
What this trial is testing

An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)

Who this might be right for
Kidney Disease
Amgen
Testing effectiveness (Phase 2)UnknownNCT02403362
What this trial is testing

Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Jiangsu Hansoh Pharmaceutical Co., Ltd. 60
Not applicableStudy completedNCT00396123
What this trial is testing

Effects Of Darbepoetin On Vascular Repair Mechanisms In Kidney Disease The DARBEPC Study

Who this might be right for
Chronic Kidney DiseaseAnemia
University of Michigan 12
Testing effectiveness (Phase 2)Study completedNCT00542568
What this trial is testing

Safety and Efficacy of Sustained Erythropoietin Therapy

Who this might be right for
Anemia
Medgenics Medical Israel Ltd. 19
Testing effectiveness (Phase 2)Study completedNCT00337935
What this trial is testing

The Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.

Who this might be right for
Renal Failure , ChronicAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 157
Early research (Phase 1)Ended earlyNCT05878704
What this trial is testing

Study of GBT021601 in Participants With Renal Impairment

Who this might be right for
Renal Impairment
Pfizer 8
Testing effectiveness (Phase 2)Study completedNCT01977573
What this trial is testing

Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

Who this might be right for
Anaemia
GlaxoSmithKline 252
Testing effectiveness (Phase 2)Ended earlyNCT00240734
What this trial is testing

Treatment of Anemia in Diabetic Subjects With CKD

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 11
Large-scale testing (Phase 3)Ended earlyNCT00680563
What this trial is testing

Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA.

Who this might be right for
Anemia
Hoffmann-La Roche 4
Large-scale testing (Phase 3)Study completedNCT00116701
What this trial is testing

Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis

Who this might be right for
Kidney Disease
Amgen 200
Large-scale testing (Phase 3)UnknownNCT04239391
What this trial is testing

Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)

Who this might be right for
End Stage Renal Disease
Rockwell Medical Technologies, Inc. 150
Not applicableStudy completedNCT04670094
What this trial is testing

Comorbidities and Risk Score in COVID-19 Patients

Who this might be right for
Covid19
University of Milano Bicocca 4,555
Large-scale testing (Phase 3)Study completedNCT00545571
What this trial is testing

MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal Anemia

Who this might be right for
Anemia
Hoffmann-La Roche 120
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation